Drug Interactions With Phosphodiesterase-5 Inhibitors Used for the Treatment of Erectile Dysfunction or Pulmonary Hypertension

Key Points

• The aim is to investigate potential drug interactions with phosphodiesterase-5 inhibitors in the context of erectile dysfunction and pulmonary hypertension treatment.
• Conducted a randomized trial to assess the effects of various medications combined with phosphodiesterase-5 inhibitors.
• Analyzed interaction effects on treatment efficacy and safety in patients with erectile dysfunction and pulmonary hypertension.
• Significant interactions observed with common antihypertensive medications, negatively affecting treatment outcomes.
• Increased rates of vasodilation-related side effects in patients taking multiple interacting drugs.